{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Patient+Level&page=20", "query": { "intervention": "Patient Level", "page": 20 }, "page_size": 10 }, "pagination": { "page": 20, "page_size": 10, "total_count": 6241, "total_pages": 625, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Patient+Level&page=21&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Patient+Level&page=19&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-28T19:45:00.169Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03217838", "title": "Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute Myeloid Leukaemia" ], "interventions": [ { "name": "AZD2811", "type": "DRUG" }, { "name": "Azacitidine", "type": "DRUG" }, { "name": "Venetoclax", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 50, "start_date": "2017-07-31", "completion_date": "2021-03-25", "has_results": false, "last_update_posted_date": "2022-04-05", "last_synced_at": "2026-10-28T19:45:00.169Z", "location_count": 10, "location_summary": "Denver, Colorado • Sarasota, Florida • Detroit, Michigan + 7 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Canton", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03217838" }, { "nct_id": "NCT04278768", "title": "Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Acute Myelogenous Leukemia", "Myelodysplastic Syndrome" ], "interventions": [ { "name": "Emavusertib", "type": "DRUG" }, { "name": "Venetoclax", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Curis, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 366, "start_date": "2020-07-06", "completion_date": "2026-04-01", "has_results": false, "last_update_posted_date": "2026-03-19", "last_synced_at": "2026-10-28T19:45:00.169Z", "location_count": 12, "location_summary": "Tampa, Florida • Atlanta, Georgia • Chicago, Illinois + 8 more", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04278768" }, { "nct_id": "NCT01496573", "title": "Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Alveolar Childhood Rhabdomyosarcoma", "Childhood Rhabdomyosarcoma", "Embryonal Childhood Rhabdomyosarcoma" ], "interventions": [ { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 77, "start_date": "2011-12", "completion_date": "2016-05", "has_results": false, "last_update_posted_date": "2016-05-19", "last_synced_at": "2026-10-28T19:45:00.169Z", "location_count": 1, "location_summary": "Monrovia, California", "locations": [ { "city": "Monrovia", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01496573" }, { "nct_id": "NCT01585805", "title": "Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Locally Advanced Pancreatic Adenocarcinoma", "Metastatic Pancreatic Adenocarcinoma", "Stage III Pancreatic Cancer AJCC v8", "Stage IV Pancreatic Cancer AJCC v8" ], "interventions": [ { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Gemcitabine Hydrochloride", "type": "DRUG" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Veliparib", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 83, "start_date": "2012-05-15", "completion_date": "2027-03-09", "has_results": true, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-10-28T19:45:00.169Z", "location_count": 9, "location_summary": "Chicago, Illinois • Harvey, Illinois • Ann Arbor, Michigan + 6 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Harvey", "state": "Illinois" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Basking Ridge", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01585805" }, { "nct_id": "NCT03770494", "title": "A Study of LY3405105 in Participants With Advanced Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumor" ], "interventions": [ { "name": "LY3405105", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 54, "start_date": "2019-01-31", "completion_date": "2021-02-04", "has_results": true, "last_update_posted_date": "2025-11-04", "last_synced_at": "2026-10-28T19:45:00.169Z", "location_count": 7, "location_summary": "Fayetteville, Arkansas • New Haven, Connecticut • New York, New York + 3 more", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03770494" }, { "nct_id": "NCT04173026", "title": "Dissemination and Implementation of Stroke Prevention Looking at the Care Environment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sickle Cell Disease" ], "interventions": [ { "name": "Provider-level intervention", "type": "OTHER" }, { "name": "Patient-level intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": "7 Years", "sex": "ALL", "summary": "2 Years to 7 Years" }, "enrollment_count": 16, "start_date": "2020-06-04", "completion_date": "2023-06-30", "has_results": false, "last_update_posted_date": "2023-07-03", "last_synced_at": "2026-10-28T19:45:00.169Z", "location_count": 15, "location_summary": "Little Rock, Arkansas • Oakland, California • Wilmington, Delaware + 10 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Oakland", "state": "California" }, { "city": "Wilmington", "state": "Delaware" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04173026" }, { "nct_id": "NCT05336955", "title": "Evaluation of Telehealth Services on Mental Health Outcomes for People With Intellectual and Developmental Disabilities", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Mental Health Conditions", "Developmental Disability" ], "interventions": [ { "name": "Intake and quarterly assessment:", "type": "OTHER" }, { "name": "Consultation & coping skills coaching:", "type": "OTHER" }, { "name": "24-hour urgent crisis response and intervention:", "type": "OTHER" }, { "name": "Service linkages, referrals, outreach, & training:", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of New Hampshire", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "12 Years to 45 Years" }, "enrollment_count": 339, "start_date": "2023-05-01", "completion_date": "2027-01-01", "has_results": false, "last_update_posted_date": "2026-05-11", "last_synced_at": "2026-10-28T19:45:00.169Z", "location_count": 1, "location_summary": "Concord, North Carolina", "locations": [ { "city": "Concord", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05336955" }, { "nct_id": "NCT02959840", "title": "Acupuncture Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Nausea", "Vomiting", "Satisfaction" ], "interventions": [ { "name": "Acupressure Point P6 stimulator", "type": "DEVICE" }, { "name": "Metoclopramide", "type": "DRUG" }, { "name": "Ondansetron", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Rutgers, The State University of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 180, "start_date": "2015-07", "completion_date": "2017-08-23", "has_results": true, "last_update_posted_date": "2017-09-25", "last_synced_at": "2026-10-28T19:45:00.169Z", "location_count": 1, "location_summary": "New Brunswick, New Jersey", "locations": [ { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02959840" }, { "nct_id": "NCT06787586", "title": "Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Normal Volunteers", "Atopic Dermatitis (AD)", "Atopic Eczema", "Chronic Pruritus" ], "interventions": [ { "name": "ATTO-1310", "type": "DRUG" }, { "name": "ATTO-1310 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Attovia Therapeutics Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 108, "start_date": "2025-01-14", "completion_date": "2026-06-11", "has_results": false, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-10-28T19:45:00.169Z", "location_count": 11, "location_summary": "Encinitas, California • Rocklin, California • Sacramento, California + 7 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Rocklin", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Margate", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06787586" }, { "nct_id": "NCT06528470", "title": "Posterior Tibial Nerve Stimulation for Children With Pelvic Floor Dyssynergia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Constipation", "Fecal Incontinence in Children", "Pelvic Floor Dyssynergia" ], "interventions": [ { "name": "Posterior Tibial Nerve Stimulation (PTNS)", "type": "DEVICE" }, { "name": "Sham Stimulation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Nationwide Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "8 Years to 18 Years" }, "enrollment_count": 40, "start_date": "2020-01-09", "completion_date": "2024-12-30", "has_results": false, "last_update_posted_date": "2026-03-06", "last_synced_at": "2026-10-28T19:45:00.169Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06528470" } ] }